Craneware plc AGM Statement (9153F)
18 November 2015 - 8:16PM
UK Regulatory
TIDMCRW
RNS Number : 9153F
Craneware plc
17 November 2015
Craneware plc
("Craneware" or the "Company")
AGM Statement
17 November 2015 - Craneware plc (AIM: CRW.L), the leader in
Value Cycle solutions for the US healthcare market, will be holding
its Annual General Meeting today at 9am. At the meeting, Keith
Neilson, CEO of the Company, will make the following statement:
"We have experienced a positive start to trading in the first
few months of the year. In June, we launched the Value Cycle, our
vision for the process and culture by which healthcare providers
pursue quality patient outcomes and optimal financial performance
within a healthcare market moving towards value-based care. Our
leadership in this area has further strengthened Craneware's
position as a trusted partner for US healthcare organisations as
they look to solve the challenges of the new value based
reimbursement models.
This positive impact of the Value Cycle on the level of sales
activity combined with the contribution of the prior year's sales
flowing through to the current year financial results and the
continued high levels of cash generation, mean we are well
positioned to continue to execute on our growth strategy."
Craneware will be hosting an analyst and investor presentation
at 11am today. The presentation to be given at the meeting will
cover topics including the evolution of the US healthcare market
towards value-based care, the escalation of patient engagement and
consumerism, and the Value Cycle. The presentation will contain no
new material information.
Copies of the presentation will be made available on the
Company's website at www.craneware.com.
For further information, please contact:
Craneware plc Peel Hunt Alma
+44 (0)131 +44 (0)20 7418 +44 (0)7515 805
550 3100 8900 218
Keith Neilson, Dan Webster Caroline Forde
CEO
Craig Preston, Richard Kauffer Hilary Buchanan
CFO
About Craneware
Craneware is the leader in automated value cycle solutions that
help US provider organisations discover, convert and optimise
assets to achieve best clinical outcomes and financial performance.
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland
with offices in Atlanta, Boston, Nashville and Phoenix employing
over 200 staff. Craneware's market-driven, SaaS solutions normalise
disparate data sets, bringing in up-to-date regulatory and
financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMBCBDBUGBBGUL
(END) Dow Jones Newswires
November 17, 2015 02:00 ET (07:00 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024